A new clinical entity in T704M mutation in periodic paralysis

Simple item page
dc.contributor.authorGun Bilgic D.
dc.contributor.authorAydin Gumus A.
dc.contributor.authorGerik Celebi H.B.
dc.contributor.authorBilgic A.
dc.contributor.authorUnaltuna Erginel N.
dc.contributor.authorCam F.S.
dc.date.accessioned2025-04-10T11:06:20Z
dc.date.available2025-04-10T11:06:20Z
dc.date.issued2020
dc.description.abstractPeriodic paralyses (PPs) are a group of rare disorders characterized by episodic, sudden-onset, flaccid paralysis of skeletal muscles usually resulting in complete recovery after the attacks. PPs are caused by abnormal, mostly potassium-sensitive excitability of the muscle tissue. Hypokalemic and hyperkalemic periodic paralysis (HypoKPP and HyperKPP) have been described according to their characteristic phenotypes and the serum potassium level during the attacks of weakness. The T704M mutation on the SCN4A gene is the most common mutation in HyperKPP. Different mutations of the SCN4A gene have also been reported in some cases of HypoKPP. In this study, a large Turkish family carrying the T704M mutation on the SCN4A gene with HypoKPP disease was examined. A similar history was noted in a total of 17 subjects in the pedigree. SCN4A gene of the patients was sequenced with Sanger sequencing. In this study, this mutation was associated with a HypoKKP diagnosis for the first time in the literature. The symptoms of hallucination and diplopia seen in patients had also never been indicated in the literature before. This report expands the phenotypic variability of the T704M mutation, further confirming the lack of genotype-phenotype correlation in SCN4A mutations. © 2020 Elsevier Ltd
dc.identifier.DOI-ID10.1016/j.jocn.2020.04.061
dc.identifier.urihttp://hdl.handle.net/20.500.14701/46628
dc.publisherChurchill Livingstone
dc.titleA new clinical entity in T704M mutation in periodic paralysis
dc.typeArticle

Files

Collections

Scopus Koleksiyonu